Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT)

Abstract Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In response to the still ongoing pandemic outbreak, a number of COVID-19 vaccines have been quickly developed and deployed. Although minor adverse events, either local (e.g., soreness, itch, redness) or systematic (fever, malaise, headache, etc.), are not uncommon following any COVID-19 vaccination, one rare vaccine-associated event can cause fatal consequences due to development of antibodies against platelet factor 4 (PF4), which trigger platelet activation, aggregation, and possible resultant thrombosis, often at unusual vascular sites. Termed thrombosis with thrombocytopenia syndrome (TTS) by reporting government agencies, the term vaccine-induced (immune) thrombotic thrombocytopenia (VITT) is more widely adopted by workers in the field. In response to increasing reports of VITT, several expert groups have formulated guidelines for diagnosis and/or management of VITT. Herein, we review some key guidelines related to diagnosis of VITT, and also provide some commentary on their development and evolution.

[1]  T. Warkentin Vaccine-induced immune thrombotic thrombocytopenia (VITT) , 2022, Seminars in Hematology.

[2]  J. Curnow,et al.  Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia , 2021, The Medical journal of Australia.

[3]  M. Pai,et al.  Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination , 2021, Thrombosis and Haemostasis.

[4]  G. Ambler,et al.  Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis , 2021, The New England journal of medicine.

[5]  G. Lippi,et al.  Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. , 2021, JAMA cardiology.

[6]  J. Kelton,et al.  Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia , 2021, Nature.

[7]  M. Dimopoulos,et al.  High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events , 2021, Vaccines.

[8]  S. Noronha,et al.  Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine , 2021, Annals of Internal Medicine.

[9]  A. Cuker,et al.  Thrombosis After Vaccination With Messenger RNA–1273: Is This Vaccine-Induced Thrombosis and Thrombocytopenia or Thrombosis With Thrombocytopenia Syndrome? , 2021, Annals of Internal Medicine.

[10]  E. Favaloro Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia , 2021, International journal of laboratory hematology.

[11]  P. Choi Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. , 2021, The New England journal of medicine.

[12]  S. Ting,et al.  The first known case of vaccine‐induced thrombotic thrombocytopenia in Australia , 2021, The Medical journal of Australia.

[13]  S. de Lusignan,et al.  First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland , 2021, Nature Medicine.

[14]  J. Kelton,et al.  Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia , 2021, The New England journal of medicine.

[15]  M. Makris,et al.  Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT) , 2021, Research and Practice in Thrombosis and Haemostasis.

[16]  S. Susen,et al.  PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia , 2021, The New England journal of medicine.

[17]  A. Greinacher,et al.  Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2 , 2021, Blood.

[18]  J. Oldenburg,et al.  Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH , 2021, Hämostaseologie.

[19]  M. Schull,et al.  Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID-19 Vaccination: Lay Summary , 2021 .

[20]  E. Woo,et al.  US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. , 2021, JAMA.

[21]  Anna Eriksson,et al.  An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination , 2021, Journal of Thrombosis and Haemostasis.

[22]  D. Goldblatt,et al.  Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination , 2021, The New England journal of medicine.

[23]  G. Tiscia,et al.  Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET). , 2021, Blood transfusion = Trasfusione del sangue.

[24]  S. Koepsell,et al.  Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination , 2021, The New England journal of medicine.

[25]  Fridtjof Lund-Johansen,et al.  Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination , 2021, The New England journal of medicine.

[26]  J. Oldenburg,et al.  Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH , 2021, Hämostaseologie.

[27]  S. Eichinger,et al.  A Prothrombotic Thrombocytopenic Disorder Resembling Heparin-Induced Thrombocytopenia Following Coronavirus-19 Vaccination , 2021 .

[28]  E. Favaloro,et al.  Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment , 2021, Expert review of hematology.

[29]  C. Demirdover COVID-19-vaccines , 2021, Reactions Weekly.

[30]  E. Duncan,et al.  A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia. , 2020, Pathology (Sydney).

[31]  E. Favaloro,et al.  Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update. , 2017, Pathology.

[32]  K. Chalkidou About the National Institute for Health and Care Excellence - NICE. , 2013, Acta medica portuguesa.

[33]  J. R. Scotti,et al.  Available From , 1973 .